Last reviewed · How we verify
NCT04774588: Holo-Stream
HoloStream Study - Video Capture Device Usage
NA trial testing VSI streamer and Microsoft Hololens 2 classed as a Class III device by Health Canada. in Nephrostomy; Complications in 100 participants. Status unknown.
1 April 2022
Quick facts
| Lead sponsor | University of Calgary |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | other |
| Enrollment | 100 |
| Start date | 1 March 2021 |
| Primary completion | 1 April 2022 |
| Estimated completion | 1 April 2022 |
Drugs / interventions tested
- VSI streamer and Microsoft Hololens 2 classed as a Class III device by Health Canada.
Conditions studied
- Nephrostomy; Complications — all drugs for Nephrostomy; Complications →
- Fistula — all drugs for Fistula →
- Central Venous Catheter Thrombosis — all drugs for Central Venous Catheter Thrombosis →
Sponsor
University of Calgary
Who can join
Adults 18 to 99, any sex, with Nephrostomy; Complications or Fistula. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Objectives: Primary * Evaluate the primary operator usability of VSI streaming software for realtime streaming of images from video capture devices to a head mounted display (Hololens 2) during Interventional Radiology procedures Secondary * Evaluate Radiographer usability of VSI streaming software. * Develop suggestions for future research studies to assess the safety and efficacy of the VSI streamer software during other Interventional radiology procedures * Evaluate the impact of VSI streaming software on room setup time, procedural time and fluoroscopy time * Assess the feasability of remote collaboration by real time image transmission between remote devices through 3D telemedicine
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04774588
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other University of Calgary trials
Trials by the same sponsor.
- NCT06885996 — Psilocybin-assisted Therapy for Post-Traumatic Stress Disorder in Survivors of Intimate Partner Violence · Phase 2 · not yet recruiting
- NCT05729503 — Effect of SPG Block for Patients With Anxiety at Electronic Dance Music Festivals · Phase 2 · not yet recruiting
- NCT07463339 — Microbiome-guided Prophylaxis to Reduce Ventilator-Associated Pneumonia in Intensive Care Units: A Pilot Randomized Cont · Phase 2 · not yet recruiting
- NCT07145645 — Topical Diclofenac vs.Oral Ibuprofen for MSK Pain in Children · Phase 3 · recruiting
- NCT07280325 — Moxie Self-Management and Education Support Program · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04774588 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Calgary
- Last refreshed: 1 March 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04774588.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing